¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"neutrophil myelocyte"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® neutrophil ÇÑ±Û Áß¼º±¸
¼³¸í   
  ¿°»ö»ó »êµµ°¡ Áß¼ºÀΠ»óÅ¿¡¼­ ¼¼Æ÷Áú³»¿¡ Á¸ÀçÇϴ ¿©·¯ °ú¸³µéÀÌ ³ªÅ¸³ª±â ¶§¹®¿¡ Áß¼º±¸¶ó°í ºÒ¸®¸ç, ¶ÇÇÑ ¼¼Æ÷³»ÀÇ ÇÙÀÇ ÇüŰ¡ ´Ù¾çÇϹǷΠ´ÙÇü¹éÇ÷±¸¶ó°íµµ ÇÑ´Ù. ±â´ÉÀº ÁַΠ½Åü³»¿¡ Ä§ÀÔÇϴ º´±ÕÀ» Àâ¾Æ¸ÔÀ½À¸·Î½á Ç×±ÕÀÛ¿ëÀ» ¼öÇàÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acidophilic myelocyte
    È£»ê°ñ¼ö¼¼Æ÷
  • basophilic myelocyte
    È£¿°±â°ñ¼ö¼¼Æ÷
  • eosinophilic myelocyte
    È£»ê°ñ¼ö¼¼Æ÷
  • myelocyte
    °ñ¼ö¼¼Æ÷, °ñ¼ö±¸, »À¼ÓÁú¼¼Æ÷
  • neutrophilic myelocyte
    Áß¼º±¸°ñ¼ö¼¼Æ÷, È£Áß¼º°ñ¼ö¼¼Æ÷
  • band neutrophil
    ¶ìÁß¼º±¸
  • hypersegmented neutrophil
    °ú´ÙºÐ¿±ÇÙÁß¼º±¸
  • juvenile neutrophil
    ¼Ò¾ÆÁß¼º±¸, ÃʱâÁß¼º±¸
  • neutrophil
    Áß¼º±¸, È£Áß±¸
  • neutrophil chemotactic factor
    Áß¼º±¸È­ÇÐÁÖ¼ºÀÎÀÚ, È£Áß±¸½ò¸²ÀÎÀÚ
  • neutrophil granule
    È£Áß¼º°ú¸³
  • neutrophil leukocyte
    Áß¼º¹éÇ÷±¸, È£Áß¹éÇ÷±¸
  • nonfilamented neutrophil
    ¹«¹Ì¼¼¼¶À¯Áß¼º±¸
  • segmented neutrophil
    ºÐ¿±ÇÙÁß¼º±¸
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myelocyte
    °ñ¼ö¼¼Æ÷, »À¼ÓÁú¼¼Æ÷
  • neutrophil
    Áß¼º±¸
  • band neutrophil
    ¶ìÁß¼º±¸
  • hypersegmented neutrophil
    °ú´ÙºÐ¿±ÇÙÁß¼º±¸
  • segmented neutrophil
    ºÐ¿±ÇÙÁß¼º±¸
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acidophilic myelocyte
    È£»ê¼º°ñ¼ö¼¼Æ÷
  • basophilic myelocyte
    È£¿°±â°ñ¼ö¼¼Æ÷
  • eosinophilic myelocyte
    È£»ê¼º°ñ¼ö¼¼Æ÷
  • myelocyte
    °ñ¼ö¼¼Æ÷, »À¼ÓÁú¼¼Æ÷
  • neutrophilic myelocyte
    È£Áß¼º°ñ¼ö¼¼Æ÷
  • band neutrophil
    ¶ìÈ£Áß±¸
  • neutrophil chemotactic factor
    È£Áß±¸ÁÖ¼ºÀÎÀÚ, È£Áß±¸½ò¸²ÀÎÀÚ
  • neutrophil granule
    È£Áß±¸µ¶¼º°ú¸³
  • hypersegmented neutrophil
    °ú´ÙºÐȹȣÁß±¸
  • juvenile neutrophil
    À¯¾àÈ£Áß±¸, ÃʱâÈ£Áß±¸
  • neutrophil leukocyte
    È£Áß¼º¹éÇ÷±¸
  • neutrophil
    È£Áß¼º¹éÇ÷±¸, È£Áß±¸
  • nonfilamented neutrophil
    ¹«¹Ì¼¼¼¶À¯È£Áß±¸
  • segmented neutrophil
    ºÐ¿±ÇÙÈ£Áß±¸
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acidophilic myelocyte
    È£»ê¼º°ñ¼ö¼¼Æ÷
  • polymorphonuclear neutrophil =PMN
    ´ÙÇüÇ٠ȣÁß±¸
  • polymorphonuclear neutrophil[e]
    ´ÙÇÙÈ£Áß±¸
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neutrophil myelocyte
    Áß¼ºÈ£¼º °ñ¼ö¼¼Æ÷, È£Áß¼º °ñ¼ö?~ÍéâÐϹ).
  • neutrophil myelocyte
    Áß¼ºÈ£¼º °ñ¼ö¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acidophilic myelocyte
    È£»ê¼º°ñ¼ö¼¼Æ÷
  • basophilic myelocyte
    È£¿°±â¼º °ñ¼ö±¸(?Ë­ËàË´).
  • basophilic myelocyte
    È£¿°±â¼º°ñ¼ö¼¼Æ÷
  • eosinophilic myelocyte
    »êÈ£¼º °ñ¼ö¼¼Æ÷.[ÀÇ]È£»ê±¸¼º °ñ¼ö¼¼Æ÷.
  • myelocyte
    °ñ¼ö¼¼Æ÷(ÍéâÐá¬øà), °ñ¼ö±¸(ÍéâÐϹ).
  • myelocyte
    °ñ¼ö¼¼Æ÷ »À¼ÓÁú¼¼Æ÷
  • myelocyte
    °ñ¼ö¼¼Æ÷(Ë­ËàËṴ̂), °ñ¼ö±¸(Ë­ËàË´).
  • myelocyte
    °ñ¼ö¼¼Æ÷
  • neutrophilic myelocyte
    È£Áß(¼º) °ñ¼ö±¸(~Ë­ËàË´), Áß¼ºÄ£È­(¼º) °ñ¼ö±¸(Ì¡ËÛ̴̬ËÛË­ËàË´)
  • neutrophilic myelocyte
    È£Áß¼º°ñ¼ö¼¼Æ÷
  • neutrophilic myelocyte
    È£Áß(¼º) °ñ¼ö±¸(¡­ ÍéâÐϹ), Áß¼ºÄ£È­(¼º) °ñ¼ö±¸(ñéàõöÑûúàõÍéâÐϹ)
  • band neutrophil
    ´ëÈ£Áß±¸(Óáû¿ñéϹ)
  • juvenile neutrophil
    À¯¾àÈ£Áß±¸(ËôËâ̴̡˴) Èİñ¼ö±¸(Ì·Ë­ËàË´) .
  • juvenile neutrophil
    À¯¾àÈ£Áß±¸(êêå´û¿ñéϹ) Èİñ¼ö±¸(ý­ÍéâÐϹ) .
  • neutrophil
    È£Áß±¸
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Acidophilic myelocyte
    È£»ê¼º°ñ¼ö¼¼Æ÷
    [¿¾ ¿ë¾î] »êÈ£¼º°ñ¼ö¼¼Æ÷
  • Basophilic myelocyte
    È£¿°±â¼º°ñ¼ö¼¼Æ÷
    [¿¾ ¿ë¾î] ¿°±âÈ£¼º°ñ¼ö¼¼Æ÷
  • Neutrophilic myelocyte
    È£Áß¼º°ñ¼ö¼¼Æ÷
    [¿¾ ¿ë¾î] Áß¼ºÈ£¼º°ñ¼ö¼¼Æ÷
  • Myelocyte
    °ñ¼ö¼¼Æ÷ [»À¼ÓÁú¼¼Æ÷]
    [¿¾ ¿ë¾î] °ñ¼ö¼¼Æ÷
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neutrophil
    È£Áß±¸, È£Áß¼ºÀÇ, Áß¼ºÄ£È­(¼º)ÀÇ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
NAP nasion, point A, pogonion [convexity or concavity of the facial profile]; nerve action potential; ne...
AML Acute Myelogenous Leukemia
  Morphologic Classification(FABºÐ·ù)
   &n...
M3 absolute dullness; myelocyte at the 3rd stage of maturation
M4 myelocyte at the 4th stage of maturation
M6 band form in the 6th stage of myelocyte maturation
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CINC 8/cytokine-induced neutrophil chemoattractant
ANC Absolute Neutrophil Count
ANCA Anti-Neutrophil Cytoplasmic Antibodies
ANCA Anti-Neutrophil Cytoplasmic Antibody
ANCA Anti-neutrophil cytoplasm antibodies
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • myelocyte
    °ñ¼ö ¼¼Æ÷, °ñ¼ö±¸
    Àü°ñ¼ö ¼¼Æ÷°¡ Áõ½ÄÇÏ°í ºÐÈ­ÇÑ °ÍÀ¸·Î Å©±â´Â Áö¸§ÀÌ ¾à 12-15§­ÀÌ´Ù. ÀÌ ¼¼Æ÷¿¡¼­ ÇÑ ¹ø ´õ ¼¼Æ÷ ºÐ¿­ÀÌ ÀϾ ÈÄ¿¡´Â ´õ ÀÌ»óÀÇ ¼¼Æ÷ ºÐ¿­Àº ÀϾÁö ¾Ê°í, ¼º¼÷ÀÌ ´õ °è¼ÓµÉ »ÓÀÌ´Ù.
  • neutrophilic myelocyte
    È£Áß °ñ¼ö±¸, È£Áß¼º °ñ¼ö±¸, Áß¼º ģȭ °ñ¼ö±¸, Áß¼º ģȭ¼º °ñ¼ö±¸
  • juvenile neutrophil
    À¯¾à È£Áß±¸
  • neutrophil
    È£Áß±¸, È£Áß¼ºÀÇ, Áß¼º ģȭÀÇ, Áß¼º ģȭ¼ºÀÇ
    1. °ñ¼ö ¼Ó¿¡¼­ Çü¼ºµÇ´Â ¹éÇ÷±¸ÀÇ ÀÏÁ¾À¸·Î ³»ºÎ¿¡ Áß¼º ¿°»ö¼º °ú¸³À» Æ÷ÇÔÇϰí ÀÖ´Ù. 2. Áß¼º »ö¼Ò·Î ½±°Ô ¿°»öµÇ´Â ¸ðµç ¼¼Æ÷, ±¸Á¶¹° ¶Ç´Â Á¶Á÷ ¼ººÐ. 3. â»ó ºÎÀ§¿¡ óÀ½À¸·Î µé¾î¿À´Â ¿°Áõ ¼¼Æ÷·Î¼­ ¼ö¸íÀÌ Âª¾Æ Á¶Á÷ÀÌ ¼Õ»óÀ» ¹ÞÀº ÈÄ ¸î ½Ã°£ À̳»¿¡ ÃâÇöÇÏ¿© 24½Ã°£ ÈÄ ÃÖ°íÁ¶¿¡ ´ÞÇÏ´Ù°¡ °ð º¯¼ºµÇ¾î ¾ø¾îÁø´Ù.
  • neutrophil dysfunction syndrome
    È£Áß±¸ ±â´É Àå¾Ö ÁõÈıº
  • neutrophil granule
    È£Áß¼º °ú¸³, Áß¼º ģȭ °ú¸³, Áß¼º ģȭ¼º °ú¸³
  • neutrophil leucocyte
    È£Áß¼º ¹éÇ÷±¸, Áß¼º È£¼º ¹éÇ÷±¸
    »ýü¿¡¼­ 7-9§­, µµ¸» Ç¥º»¿¡¼­ 10-12§­ÀÇ Á÷°æÀ» °®°í ÀÖ´Ù. ÇÙÀÇ ¸ð¾çÀº ´Ù¾çÇÑ ºÐ¿± »óŸ¦ ÀÌ·ç´Âµ¥, ºÐ¿±ÀÇ ¼ö´Â 3-5°³ÀÌ°í ºÐ¿± ÇÙ³¢¸®´Â ¹Ì¼¼ÇÑ ¿°»ö»ç·Î ¿¬°áµÇ¾î ÀÖÀ¸¸ç ÇÙ ¼Òü´Â °üÂûµÇÁö ¾Ê´Â´Ù.
  • segmented neutrophil
    ºÐÀý±¸ ÇÙ
    °¡Àå ºÐÈ­ ¼º¼÷µÈ ÇüÅÂÀÇ È£Áß±¸.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
myelocyte A motile cell produced by and found in the bone marrow which develops intogranular leukocytes.
(09 Oct 1997)
myelocyte A The youngest form of myelocyte, characterised by only a few (not more than ten) cytoplasmic granules, which are most reliably demonstrated by means of staining with neutral red; the mitochondria are numerous, and resemble those of the myeloblast.
(05 Mar 2000)
myelocyte B The intermediate form of myelocyte, characterised by approximately 30 to 100 (or more) cytoplasmic granules scattered among the mitochondria; the latter are less numerous than in myelocyte's of the A stage, and they are frequently displaced toward the periphery of the cell.
(05 Mar 2000)
myelocyte C The most mature of the myelocyte's characterised by numerous cytoplasmic granules that are recognizable as neutrophilic, eosinophilic, and basophilic; with neutral red these are stained, respectively, red, bright yellow, and deep maroon; C myelocyte's are frequently larger than earlier forms; if the nucleus is indented, the myelocyte is maturing into a metamyelocyte.
(05 Mar 2000)
anionic neutrophil activating peptide <cytokine> A cytokine that activates neutrophils and attracts neutrophils and T-lymphocytes.
It is released by several cell types including monocytes, macrophages, T-lymphocytes, fibroblasts, endothelial cells, and keratinocytes by an inflammatory stimulus. Il-8 is a member of the beta-thromboglobulin superfamily and structurally related to platelet factor 4.
Acronym: IL-8
(12 Dec 1998)
band neutrophil <pathology> Immature neutrophils released from the bone marrow reserve in response to acute demand.
(18 Nov 1997)
mature neutrophil A fully matured neutrophil that has at least 2 (and as many as 5) distinct lobes in the nucleus and manifests active ameboid motion.
Synonym: mature neutrophil.
(05 Mar 2000)
monocyte derived neutrophil chemotactic factor <cytokine> A cytokine that activates neutrophils and attracts neutrophils and T-lymphocytes.
It is released by several cell types including monocytes, macrophages, T-lymphocytes, fibroblasts, endothelial cells, and keratinocytes by an inflammatory stimulus. Il-8 is a member of the beta-thromboglobulin superfamily and structurally related to platelet factor 4.
Acronym: IL-8
(12 Dec 1998)
segmented neutrophil A fully matured neutrophil that has at least 2 (and as many as 5) distinct lobes in the nucleus and manifests active ameboid motion.
Synonym: mature neutrophil.
(05 Mar 2000)
hypersegmented neutrophil An aged and degenerated neutrophil in which there may be 6 to 10 lobes in the nucleus.
Immature neutrophil, a young neutrophil; the term is usually used with reference to stab neutrophil's (or other "juvenile" neutrophil's), neutrophilic granulocytes in which the nucleus is indented but not distinctly segmented.
Juvenile neutrophil, any cell of the granulocytic series in which the neutrophilic granules are recognizable and the nucleus is indented (the first phase of segmentation).
(05 Mar 2000)
stab neutrophil <pathology> Immature neutrophils released from the bone marrow reserve in response to acute demand.
(18 Nov 1997)
neutrophil <haematology> A granulocyte, a white blood cell.
(18 Nov 1997)
neutrophil activating factor <cytokine> A cytokine that activates neutrophils and attracts neutrophils and T-lymphocytes.
It is released by several cell types including monocytes, macrophages, T-lymphocytes, fibroblasts, endothelial cells, and keratinocytes by an inflammatory stimulus. Il-8 is a member of the beta-thromboglobulin superfamily and structurally related to platelet factor 4.
Acronym: IL-8
(12 Dec 1998)
neutrophil activating protein <cytokine> A cytokine that activates neutrophils and attracts neutrophils and T-lymphocytes.
It is released by several cell types including monocytes, macrophages, T-lymphocytes, fibroblasts, endothelial cells, and keratinocytes by an inflammatory stimulus. Il-8 is a member of the beta-thromboglobulin superfamily and structurally related to platelet factor 4.
Acronym: IL-8
(12 Dec 1998)
neutrophil activation The process in which the neutrophil is stimulated by diverse substances, resulting in degranulation and/or generation of reactive oxygen products, and culminating in the destruction of invading pathogens. The stimulatory substances, including opsonised particles, immune complexes, and chemotactic factors, bind to specific cell-surface receptors on the neutrophil.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á